The parasite Leishmania siamensis is a zoonotic agent of leishmaniasis; infection in animals has been documented in Europe and the United States. Reported authochthonous human infections have been limited to Thailand. We report a case of human visceral Leishmania siamensis infection acquired in Guyana, suggesting colonization in South America.
A 65-year-old woman was admitted to a hospital in London, UK, during March 2014 after collapsing in the street. She was anemic and mildly thrombocytopenic (hemoglobin level 8.1 g/dL, leukocyte count 4.62 × 10 9 /L, platelet count 143 × 10 9 /L). She had been unwell for 14 months, experiencing night sweats and a steady loss of energy but was otherwise asymptomatic. She reported no fever. On examination, she had hepatic enlargement and lymphadenopathy, was afebrile, and had normal liver function test results. She also had negative serologic test results for HIV, hepatitis B, hepatitis C, and the parasitic nematode spp. Strongyloides. Her CD4 count was 790 and rheumatoid factor was weakly positive; her immunoglobulin levels were within reference ranges.
The patient was from Guyana and migrated to the Results of serologic testing for Leishmania antibodies were negative by using a Rapydtest (rK39 RDT; Apacor Ltd., Berkshire, UK) and weakly positive by using the direct agglutination test (1:3,200; cutoff 1:1,600). Leishmania DNA was extracted from the sample. Leishmania-specific PCR amplification produced positive amplicons from kinetoplast minicircle, genomic heat shock protein 70, and internal transcribed spacer 1 (ITS1) targets. The kinetoplast-specific amplicon size appeared nearest to that of Leishmania major, which is not considered an agent of visceral leishmaniasis among humans.
The size and restriction fragment length polymorphism banding pattern of the ITS1 amplicon was distinct from all previously sampled human Leishmania species. Sequencing of the ITS1 amplicon revealed either 99% or 100% identity to ITS1 sequences from Leishmania siamensis. Lower levels of identity were seen in homologs from other human Leishmania species. Phylogenetic analysis of these sequences against reference sequences from other Leishmania species confirmed they clustered with L. siamensis sequences as a monophyletic group, supported by bootstrap values of 100% (Figure) . We saw a major divergence from other Leishmania sequences.
We treated the patient with liposomal amphotericin B (AmBisome [Gilead Sciences Ltd., London, UK) at a dose of 3 mg/kg given on days 1-5, and 7-day courses beginning on days 10 and 20. She responded well and her blood test results returned to reference values. She had some mild reversible renal impairment during treatment; she recovered and did not relapse during a 10-month follow-up period.
Autochthonous human visceral leishmaniasis caused by L. siamensis was thought to be geographically confined to Thailand (1) (2) (3) (4) (5) . Many of those case-patients also showed evidence of immune deficiency, such as HIV infection (1, 3) . This patient had no evidence of immune deficiency, nor had one manifest during the follow-up period after her illness, yet she had a negative rK39 test result (which detects Leishmania antibodies) despite a visceral infection. Another patient with L. siamensis visceral leishmaniasis also had a negative rK39 test result (2); therefore, L. siamensis infections may not be detectable by rK39 testing.
The phlebotomine sand fly Sergentomyia (Neophlebotomus) gemmea is a possible vector for L. siamensis in Thailand (6) (7) (8) 
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